Press Releases

Month Year

Month Year

Jun 13, 2005

Lantus® Add-on to Oral Monotherapy Therapy Showed Improved Glycemic Control in Type 2 Diabetes Patients Compared to Oral Actos Add-on to Oral Therapy
Jun 13, 2005

Clinical Study Results Demonstrated Greater Flexibility With Mealtime Dosing of Apidra® When Compared to Regular Human Insulin
Jun 13, 2005

DATA PRESENTED AT ADA SHOWED THAT BASAL INSULIN THERAPY WITH LANTUS® ACHIEVED TARGET GLYCEMIC CONTROL IN POORLY CONTROLLED TYPE 2 DIABETES
Jun 12, 2005

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes
Jun 8, 2005

Prospective Study Published in Diabetes Care Confirms Basal Therapy with Lantus® Improves Glycemic Control in Patients with Type 2 Diabetes Poorly Controlled on Prior Insulin Regimens
Jun 2, 2005

Landmark Taxotere® Study in Early Stage Breast Cancer Published in the New England Journal of Medicine
May 31, 2005

Sanofi-aventis Annual General Meeting
May 25, 2005

UROXATRAL® (alfuzosin HCl) STUDY SHOWS IMPROVEMENT UP TO TWO YEARS IN LOWER URINARY TRACT SYMPTOMS AND SEXUAL FUNCTION IN MEN WITH ENLARGED PROSTATES
May 24, 2005

New Study Demonstrates Clinical Efficacy of Telithromycin Superior to Standard First-Line Antibiotic Therapy for Treatment of Mild to Moderate Community-Acquired Pneumonia (CAP)
May 23, 2005

New Data Demonstrate Alvesco® (ciclesonide) Significantly Reduces Oral Corticosteroid Use in Patients with Severe, Persistent Asthma

Show per page

Print
Email page
RSS